These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 800772)

  • 1. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
    Costa AL; Valenti A; Costa G; Calogero F
    G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
    Strippoli V; Torosantucci A; Simonetti N
    Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A simple medium for 5-fluorocytosine sensitiving testing (author's transl)].
    Böhm W
    Dermatol Monatsschr; 1982 May; 168(5):317-20. PubMed ID: 7049776
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo studies on synergistic antifungal activity.
    Shadomy S
    Contrib Microbiol Immunol; 1977; 4():147-57. PubMed ID: 342191
    [No Abstract]   [Full Text] [Related]  

  • 6. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
    Ellis NS; Bartlett MS; Smith JW
    Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Fluorocytosine resistance in clinical isolates of Cryptococcus neoformans.
    Chin CS; Cheong YM; Wong YH
    Med J Malaysia; 1989 Sep; 44(3):194-8. PubMed ID: 2696871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
    Hoeprich PD; Huston AC
    J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Amphotericin B and 5-fluorocytosine.
    Medoff G; Kobayashi GS
    J Infect Dis; 1975 Oct; 132(4):489-90. PubMed ID: 1102615
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of fungal infections with flucytosine.
    Harder EJ; Hermans PE
    Arch Intern Med; 1975 Feb; 135(2):231-7. PubMed ID: 1096840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancy between in vitro and in vivo antifungal activity of albendazole.
    Hardin TC; Najvar LK; Rizzo J; Fothergill AW; Rinaldi MG; Graybill JR
    J Med Vet Mycol; 1997; 35(3):153-8. PubMed ID: 9229330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice.
    Hamilton JD; Elliott DM
    J Infect Dis; 1975 Feb; 131(2):129-37. PubMed ID: 1090685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of phenothiazines against medically important yeasts.
    Eilam Y; Polacheck I; Ben-Gigi G; Chernichovsky D
    Antimicrob Agents Chemother; 1987 May; 31(5):834-6. PubMed ID: 3300543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.
    Utz CJ; Shadomy S
    J Infect Dis; 1977 Jun; 135(6):970-4. PubMed ID: 325150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
    Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; García-Cambero JP; Zaragoza O
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of 5-fluorocytosine on nucleic acid synthesis in Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus.
    Polak A; Wain WH
    Chemotherapy; 1977; 23(4):243-59. PubMed ID: 324722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Fluorocytosine--current status with special references to mode of action and drug resistance.
    Polak A
    Contrib Microbiol Immunol; 1977; 4():158-67. PubMed ID: 342192
    [No Abstract]   [Full Text] [Related]  

  • 18. 5-fluorocytosine: a replacement for amphotericin B in the treatment of candida and cryptococcus neoformans infections?
    Pankey GA; Lockwood WR; Montalvo JM
    J La State Med Soc; 1970 Dec; 122(12):365-9. PubMed ID: 5492591
    [No Abstract]   [Full Text] [Related]  

  • 19. New small-size peptides possessing antifungal activity.
    Garibotto FM; Garro AD; Masman MF; Rodríguez AM; Luiten PG; Raimondi M; Zacchino SA; Somlai C; Penke B; Enriz RD
    Bioorg Med Chem; 2010 Jan; 18(1):158-67. PubMed ID: 19959366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice.
    Gadebusch HH; Pansy F; Klepner C; Schwind R
    J Infect Dis; 1976 Nov; 134(5):423-7. PubMed ID: 792355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.